Circassia Pharmaceuticals Plc – Product Pipeline Review

Global Markets Direct’s, ‘Circassia Pharmaceuticals Plc – Product Pipeline Review – 2016’, provides an overview of the Circassia Pharmaceuticals Plc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Circassia Pharmaceuticals Plc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

The report provides a snapshot of the pipeline therapeutic landscape of Circassia Pharmaceuticals Plc

The report provides overview of Circassia Pharmaceuticals Plc including its business description, key facts, and locations and subsidiaries

The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities

The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages

The report assesses Circassia Pharmaceuticals Plc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type

The report features Circassia Pharmaceuticals Plc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

Evaluate Circassia Pharmaceuticals Plc’s strategic position with total access to detailed information on its product pipeline

Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies

Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

Identify and understand important and diverse types of therapeutics under development for Circassia Pharmaceuticals Plc

Identify potential new clients or partners in the target demographic

Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics

Devise corrective measures for pipeline projects by understanding Circassia Pharmaceuticals Plc’s pipeline depth and focus of pipeline therapeutics

Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

Table of Contents

Table of Contents 2

List of Tables 4

List of Figures 4

Circassia Pharmaceuticals Plc Snapshot 5

Circassia Pharmaceuticals Plc Overview 5

Key Information 5

Key Facts 5

Circassia Pharmaceuticals Plc - Research and Development Overview 6

Key Therapeutic Areas 6

Circassia Pharmaceuticals Plc - Pipeline Review 9

Pipeline Products by Stage of Development 9

Pipeline Products - Monotherapy 10

Pipeline Products - Combination Treatment Modalities 11

Circassia Pharmaceuticals Plc - Pipeline Products Glance 12

Circassia Pharmaceuticals Plc - Late Stage Pipeline Products 12

Phase III Products/Combination Treatment Modalities 12

Circassia Pharmaceuticals Plc - Clinical Stage Pipeline Products 13

Phase II Products/Combination Treatment Modalities 13

Phase I Products/Combination Treatment Modalities 14

Circassia Pharmaceuticals Plc - Early Stage Pipeline Products 15

Preclinical Products/Combination Treatment Modalities 15

Circassia Pharmaceuticals Plc - Drug Profiles 16

Vaccine for Grass-Induced Rhinoconjunctivitis and Asthma 16

Product Description 16

Mechanism of Action 16

R&D Progress 16

glycopyrronium bromide 17

Product Description 17

Mechanism of Action 17

R&D Progress 17

Vaccine for Asthma and Ragweed-Induced Rhinoconjunctivitis 18

Product Description 18

Mechanism of Action 18

R&D Progress 18

Vaccine for Birch Pollen Allergy 20

Product Description 20

Mechanism of Action 20

R&D Progress 20

Vaccine for House Dust Mite Induced Allergic Rhinoconjunctivitis 21

Product Description 21

Mechanism of Action 21

R&D Progress 21

(fluticasone propionate + glycopyrronium bromide + salmeterol xinafoate) 22

Product Description 22

Mechanism of Action 22

R&D Progress 22

Vaccine for Japanese Cedar Pollen Allergy 23

Product Description 23

Mechanism of Action 23

R&D Progress 23

(Inhaled Corticosteroid + Long-acting Muscarinic Antagonist) 25

Product Description 25

Mechanism of Action 25

R&D Progress 25

(Long Acting Beta-2 Agonist + Long Acting Muscarinic Receptor Antagonist) 26

Product Description 26

Mechanism of Action 26

R&D Progress 26

Vaccine for Alternaria Allergy 27

Product Description 27

Mechanism of Action 27

R&D Progress 27

Circassia Pharmaceuticals Plc - Pipeline Analysis 28

Circassia Pharmaceuticals Plc - Pipeline Products by Target 28

Circassia Pharmaceuticals Plc - Pipeline Products by Route of Administration 29

Circassia Pharmaceuticals Plc - Pipeline Products by Molecule Type 30

Circassia Pharmaceuticals Plc - Pipeline Products by Mechanism of Action 31

Circassia Pharmaceuticals Plc - Recent Pipeline Updates 32

Circassia Pharmaceuticals Plc - Dormant Projects 35

Circassia Pharmaceuticals Plc - Locations And Subsidiaries 36

Head Office 36

Other Locations & Subsidiaries 36

Appendix 37

Methodology 37

Coverage 37

Secondary Research 37

Primary Research 37

Expert Panel Validation 37

Contact Us 37

Disclaimer 38

List of Tables

List of Tables

Circassia Pharmaceuticals Plc, Key Information 5

Circassia Pharmaceuticals Plc, Key Facts 5

Circassia Pharmaceuticals Plc – Pipeline by Indication, 2016 8

Circassia Pharmaceuticals Plc – Pipeline by Stage of Development, 2016 9

Circassia Pharmaceuticals Plc – Monotherapy Products in Pipeline, 2016 10

Circassia Pharmaceuticals Plc – Combination Treatment Modalities in Pipeline, 2016 11

Circassia Pharmaceuticals Plc – Phase III, 2016 12

Circassia Pharmaceuticals Plc – Phase II, 2016 13

Circassia Pharmaceuticals Plc – Phase I, 2016 14

Circassia Pharmaceuticals Plc – Preclinical, 2016 15

Circassia Pharmaceuticals Plc – Pipeline by Target, 2016 28

Circassia Pharmaceuticals Plc – Pipeline by Route of Administration, 2016 29

Circassia Pharmaceuticals Plc – Pipeline by Molecule Type, 2016 30

Circassia Pharmaceuticals Plc – Pipeline Products by Mechanism of Action, 2016 31

Circassia Pharmaceuticals Plc – Recent Pipeline Updates, 2016 32

Circassia Pharmaceuticals Plc – Dormant Developmental Projects,2016 35

Circassia Pharmaceuticals Plc, Subsidiaries 36

List of Figures

List of Figures

Circassia Pharmaceuticals Plc – Pipeline by Top 10 Indication, 2016 7

Circassia Pharmaceuticals Plc – Pipeline by Stage of Development, 2016 9

Circassia Pharmaceuticals Plc – Monotherapy Products in Pipeline, 2016 10

Circassia Pharmaceuticals Plc – Combination Treatment Modalities in Pipeline, 2016 11

Circassia Pharmaceuticals Plc – Pipeline by Target, 2016 28

Circassia Pharmaceuticals Plc – Pipeline by Route of Administration, 2016 29

Circassia Pharmaceuticals Plc – Pipeline by Molecule Type, 2016 30

Circassia Pharmaceuticals Plc – Pipeline Products by Mechanism of Action, 2016 31

    Pricing

Discounts available for multiple report purchases.

reportstore@globalmarketsdirect.com
+44 (0) 161 359 5414

Saved reports

Analytics by GoSquared